Insider Trading activities of Global Blood Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Global Blood Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Global Blood Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Global Blood Therapeutics, Inc. since 2005. The reporting company's ticker symbol is GBT. The reporting company's CIK number is 1629137.
The total value of stock buying since 2005 is $1,402,640.
The total value of stock sales since 2005 is $100,422,590.
The total value of stock option exercises since 2005 is $390,581.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Global Blood Therapeutics, Inc. (GBT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 3,000 $97,950 1,400 $4,760
2017-09 0 $0 3,000 $90,000 1,400 $4,760
2017-08 0 $0 5,410 $162,300 48,014 $15,259
2017-07 0 $0 30,053 $893,203 28,453 $305,724
2017-06 0 $0 100,000 $2,714,989 0 $0
2017-04 0 $0 31,225 $1,037,575 0 $0
2017-03 0 $0 2,045,294 $54,963,185 0 $0
2016-12 0 $0 108,955 $1,743,388 0 $0
2016-11 0 $0 2,000,000 $38,720,000 0 $0
2016-08 0 $0 0 $0 21,429 $10,500
2016-01 1,000 $22,360 0 $0 0 $0
2015-12 1,000 $30,280 0 $0 0 $0
2015-08 67,500 $1,350,000 0 $0 25,490 $49,578

Table 2. Detailed insider stock purchases, sales, and option exercises of Global Blood Therapeutics, Inc. insiders (GBT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-17 Choi Jung (See Remarks) Sale 3,000 32.65 97,950
2017-10-17 Choi Jung (See Remarks) Option Ex 1,400 3.40 4,760
2017-09-29 Choi Jung (See Remarks) Sale 3,000 30.00 90,000
2017-09-29 Choi Jung (See Remarks) Option Ex 1,400 3.40 4,760
2017-08-31 Radovich Peter (See Remarks) Sale 2,410 30.00 72,300
2017-08-31 Choi Jung (See Remarks) Sale 3,000 30.00 90,000
2017-08-31 Choi Jung (See Remarks) Option Ex 1,400 3.40 4,760
2017-08-02 Sham Hing (See Remarks) Option Ex 21,428 .49 10,499
2017-08-01 Sham Hing (See Remarks) Option Ex 3,000 .00 0
2017-08-01 Radovich Peter (See Remarks) Option Ex 3,000 .00 0
2017-08-01 Choi Jung (See Remarks) Option Ex 4,062 .00 0
2017-08-01 Farrow Jeffrey S (Chief Financial Officer) Option Ex 3,062 .00 0
2017-08-01 Love Ted W (See Remarks) Option Ex 12,062 .00 0
2017-07-25 Patrick Deval L (Director) Sale 27,053 29.69 803,203
2017-07-25 Patrick Deval L (Director) Option Ex 27,053 11.12 300,964
2017-07-21 Choi Jung (See Remarks) Sale 3,000 30.00 90,000
2017-07-21 Choi Jung (See Remarks) Option Ex 1,400 3.40 4,760
2017-06-02 Homcy Charles J (Director) Sale 81,701 27.28 2,228,639
2017-06-01 Homcy Charles J (Director) Sale 18,299 26.58 486,350
2017-04-06 Tepper Robert I (10% Owner) Sale 31,225 33.23 1,037,575
2017-03-02 Starr Kevin P (10% Owner) Sale 2,045,294 26.87 54,963,185
2016-12-16 Starr Kevin P (10% Owner) Sale 108,955 16.00 1,743,388
2016-11-14 Starr Kevin P (10% Owner) Sale 2,000,000 19.36 38,720,000
2016-08-01 Sham Hing (Senior VP, Research) Option Ex 21,429 .49 10,500
2016-01-07 Schembri John (See Remarks) Buy 1,000 22.36 22,360
2015-12-22 Ramos Eleanor (Chief Medical Officer) Buy 1,000 30.28 30,280
2015-08-17 Sham Hing (SVP of Chemistry) Buy 2,000 20.00 40,000
2015-08-17 Sham Hing (See Remarks) Option Ex 25,490 1.95 49,578
2015-08-17 Radovich Peter (See Remarks) Buy 12,500 20.00 250,000
2015-08-17 Choi Jung (See Remarks) Buy 25,000 20.00 500,000
2015-08-17 Ramos Eleanor (Chief Medical Officer) Buy 10,000 20.00 200,000
2015-08-17 Schembri John (See Remarks) Buy 500 20.00 10,000
2015-08-17 Perry Mark L (Director) Buy 5,000 20.00 100,000
2015-08-17 Love Ted W (See Remarks) Buy 10,000 20.00 200,000
2015-08-17 Patrick Deval L (Director) Buy 2,500 20.00 50,000

Insider trading activities including stock purchases, stock sales, and option exercises of GBT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Global Blood Therapeutics, Inc. (symbol GBT, CIK number 1629137) see the Securities and Exchange Commission (SEC) website.